Opportunity Information: Apply for RFA PS 13 00104CONT16
Apply for RFA PS 13 00104CONT16
- The HHS-CDC-HHSCDCERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Natural History and Prevention of Viral Hepatitis among Alaska Natives Project." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270.
- This funding opportunity was created on Nov 12, 2015 and posted on Nov 12, 2015.
- Applicants must submit their applications by Mar 01, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Centers for Disease Control and Prevention Natural History and Prevention of Viral Hepatitis among Alaska Natives Project" is a CDC-administered funding opportunity focused on understanding and reducing the impact of viral hepatitis in Alaska Native populations. As presented, the project is framed around two connected goals: studying the natural history of viral hepatitis (how hepatitis infections develop and progress over time in real-world settings) and strengthening prevention approaches to reduce new infections and related health complications. The emphasis on Alaska Natives signals that the work is intended to address the specific epidemiology, risk factors, healthcare delivery realities, and long-term outcomes within these communities, where the burden and patterns of hepatitis infection can differ from those seen in other populations.
This opportunity is listed as a continuation award, which typically indicates ongoing support for an existing effort rather than a brand-new, open competition. The funding instrument is a cooperative agreement, meaning the CDC expects to have substantial involvement in the project beyond simply providing funds. In practice, cooperative agreements often involve close collaboration with CDC scientific and program staff, shared planning, coordinated evaluation, and alignment with CDC surveillance or prevention priorities. The activity category is "Health," and the CFDA (Catalog of Federal Domestic Assistance) number is 93.270, linking the award to a broader federal assistance program area within CDC.
Only one award was expected under this announcement, reinforcing the idea that this is designed to maintain continuity for an established program or a single primary partner with the experience, infrastructure, and community relationships needed to carry out long-term hepatitis research and prevention work in Alaska. The listing shows an award ceiling of 0, which commonly appears in continuation notices or records where the specific dollar amount is not publicly displayed in the synopsis, may be negotiated, or is handled through internal continuation processes rather than a stated maximum for competitive applicants.
Eligibility is described as "Others" with a note to see additional eligibility details, which suggests the applicant pool may be limited or specialized. In similar CDC continuation cooperative agreements, eligibility can be restricted to a current recipient, a specific organization type, or entities with demonstrated capacity and established partnerships in the target population. Given the project focus, likely candidates could include tribal health organizations, Alaska-based health systems, research institutions, or organizations with longstanding involvement in Alaska Native health programs, but the exact eligibility constraints are not included in the snippet provided.
Key administrative details include the funding opportunity number RFA PS 13 00104CONT16, the administering agency listed as HHS-CDC (CDC era office), and the timeline showing an original and current closing date of March 1, 2016. The opportunity was created and posted on November 12, 2015, indicating a relatively short window from posting to closing, which is also consistent with continuation actions where the recipient is already engaged and prepared to submit required continuation materials.
Overall, this grant opportunity supports ongoing CDC work to track, understand, and prevent viral hepatitis among Alaska Natives through a collaborative, CDC-involved cooperative agreement structure, with a single expected award and continuation status indicating it is intended to sustain an established effort rather than launch multiple new projects.
Frequently Asked Questions (FAQs)
What is the funding opportunity called?
The opportunity is titled "Centers for Disease Control and Prevention Natural History and Prevention of Viral Hepatitis among Alaska Natives Project."
Which agency is administering this opportunity?
The administering agency listed is HHS-CDC (CDC era office), meaning it is run through the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
What is the main purpose of this project?
The project is focused on understanding and reducing the impact of viral hepatitis in Alaska Native populations. It is framed around two connected goals: (1) studying the natural history of viral hepatitis and (2) strengthening prevention approaches to reduce new infections and related health complications.
What does "natural history of viral hepatitis" mean in this context?
In this listing, "natural history" refers to how hepatitis infections develop and progress over time in real-world settings, including long-term outcomes and disease patterns in the affected population.
What does "prevention" mean for this opportunity?
Prevention refers to approaches intended to reduce new hepatitis infections and to reduce related health complications. The notice emphasizes strengthening prevention approaches alongside research on disease progression.
Who is the focus population for the work?
The emphasis is on Alaska Native populations. The notice indicates the work is meant to address the specific epidemiology, risk factors, healthcare delivery realities, and long-term outcomes within these communities.
Why is this opportunity specifically focused on Alaska Natives?
The listing explains that the burden and patterns of hepatitis infection can differ in Alaska Native communities compared to other populations. The opportunity is designed to address those community-specific patterns and realities.
What type of award is this?
This opportunity is described as a continuation award, which typically indicates ongoing support for an existing effort rather than a brand-new, open competition.
What does "continuation award" imply about competition?
Based on how it is described, it suggests the funding is intended to maintain continuity for an established program or an existing partner rather than to fund multiple new applicants.
What is the funding instrument used for this opportunity?
The funding instrument is a cooperative agreement.
What does a "cooperative agreement" mean for the relationship with CDC?
A cooperative agreement means CDC expects to have substantial involvement beyond providing funds. The notice describes this as close collaboration with CDC scientific and program staff, shared planning, coordinated evaluation, and alignment with CDC surveillance or prevention priorities.
What is the activity category for this funding opportunity?
The activity category is listed as "Health."
What is the CFDA number and what is it for?
The CFDA (Catalog of Federal Domestic Assistance) number is 93.270. It links the award to a broader CDC federal assistance program area.
How many awards were expected?
Only one award was expected under this announcement.
What does it mean that only one award was expected?
The notice indicates this reinforces that the opportunity is designed to maintain continuity for a single established program or primary partner with the needed experience, infrastructure, and community relationships for long-term work in Alaska.
Is there a published maximum award amount (award ceiling)?
The listing shows an award ceiling of 0.
Does an award ceiling of 0 mean no funding is available?
Not necessarily. The notice explains that an award ceiling of 0 commonly appears in continuation notices or records where the specific dollar amount is not publicly displayed in the synopsis, may be negotiated, or is handled through internal continuation processes rather than a stated maximum for competitive applicants.
Who is eligible to apply?
Eligibility is described as "Others" with a note to see additional eligibility details. The snippet provided does not include the specific eligibility constraints.
Does the listing indicate whether eligibility is limited to certain applicants?
It suggests the pool may be limited or specialized, which is common in continuation cooperative agreements. However, the exact limitations are not included in the provided information.
What kinds of organizations might typically be involved in work like this (based on the listing's description)?
The notice suggests that likely candidates could include tribal health organizations, Alaska-based health systems, research institutions, or organizations with longstanding involvement in Alaska Native health programs, but it also notes that the exact eligibility constraints are not included in the snippet.
What is the funding opportunity number?
The funding opportunity number is RFA PS 13 00104CONT16.
When was the opportunity posted?
The opportunity was created and posted on November 12, 2015.
What is the closing date?
The original and current closing date shown is March 1, 2016.
How long was the application window?
Based on the posted date (November 12, 2015) and the closing date (March 1, 2016), the window appears relatively short, which the notice suggests is consistent with continuation actions where the recipient is already engaged and prepared to submit continuation materials.
Is this opportunity intended to support short-term or long-term work?
The description points to long-term research and prevention work, including tracking outcomes over time and sustaining an established effort in Alaska Native communities.
What overall outcome is this opportunity trying to support?
Overall, it supports ongoing CDC work to track, understand, and prevent viral hepatitis among Alaska Natives through a collaborative cooperative agreement structure, aiming to reduce new infections and related health complications while improving understanding of disease progression.
Browse more opportunities from the same agency: HHS-CDC-HHSCDCERA
Browse more opportunities from the same category: Health
Next opportunity: Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: FY16 Guidelines for Brownfields Revolving Loan Fund Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA PS 13 00104CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA PS 13 00104CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1634 Funding Number: CDC RFA GH16 1634 Agency: HHS-CDC-CGH Category: Health Funding Amount: $165,000,000 |
| Provision of comprehensive HIV/AIDS services and developing national capacity to manage HIV/AIDS programs in the Republic of Uganda Apply for CDC RFA GH12 121304CONT16 Funding Number: CDC RFA GH12 121304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Availability of Administrative Supplements to NIGMS Predoctoral Training Grants (Admin Supp) Apply for PA 16 060 Funding Number: PA 16 060 Agency: HHS-NIH11 Category: Health Funding Amount: $80,000 |
| Screening, Brief Intervention, and Referral to Treatment (SBIRT) Health Professions Student Training (SBIRT- Student Training) Apply for TI 16 002 Funding Number: TI 16 002 Agency: HHS-SAMHS Category: Health Funding Amount: $290,000 |
| Risk of Adolescence and Injury in HIV Susceptibility (RAIS) (R01) Apply for RFA AI 15 058 Funding Number: RFA AI 15 058 Agency: HHS-NIH11 Category: Health Funding Amount: $400,000 |
| Supporting Maternal and child Health Activities in Ethiopia Apply for RFI 663 16 EPCMD Funding Number: RFI 663 16 EPCMD Agency: USAID-ETH Category: Health Funding Amount: $120,000,000 |
| Guidelines for Women’s Preventive Services Apply for HRSA 16 057 Funding Number: HRSA 16 057 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Discovery/Development of Novel Therapeutics for Eukaryotic Pathogens (R21/R33) Apply for RFA AI 15 054 Funding Number: RFA AI 15 054 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in Faith-Based Organization Facilities in the Republic of Kenya under the President’s Emergency Plan for AIDS Rel Apply for CDC RFA GH16 1620 Funding Number: CDC RFA GH16 1620 Agency: HHS-CDC-CGH Category: Health Funding Amount: $23,000,000 |
| Defeat Malaria Apply for RFI 482 16 000001 Funding Number: RFI 482 16 000001 Agency: USAID-GHA Category: Health Funding Amount: $32,000,000 |
| ATSDR’s Program to Promote Localized Efforts to Reduce Environmental Exposure (APPLETREE) Apply for CDC RFA TS14 140303CONT16 Funding Number: CDC RFA TS14 140303CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Research on the Epidemiology, Prevention, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa Apply for RFA IP 16 003 Funding Number: RFA IP 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $5,000,000 |
| SUPPORTING THE GHANA HEALTH SERVICE (GHS) IN THE STRENGTHENING OF NATIONAL HEALTH MANAGEMENT SYSTEMS IN THE AREAS OF STRATEGIC INFORMATION SYSTEMS, BLOOD SAFETY, AND LABORATORY CAPACITY BUILDING UNDER THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF Apply for CDC RFA PS10 10440501SUPP16 Funding Number: CDC RFA PS10 10440501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,500,000 |
| Building Capacity for Human Resources for Health in HIV/AIDS in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1624 Funding Number: CDC RFA GH16 1624 Agency: HHS-CDC-CGH Category: Health Funding Amount: $3,200,000 |
| Improving the Capacity of University Based Medical Education and Superior Training Institutions to Provide High Quality Education in the Republic of Mozambique Under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1159SUPP Funding Number: CDC RFA GH11 1159SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Foundational Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1) Apply for RFA RM 15 019 Funding Number: RFA RM 15 019 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Strengthening the National Institutes of Health in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1158SUPP Funding Number: CDC RFA GH11 1158SUPP Agency: HHS-CDC Category: Health Funding Amount: $5,251,408 |
| NEI Clinical Study Planning Grant Program (R34) Apply for PA 16 038 Funding Number: PA 16 038 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Novel Nucleic Acid Sequencing Technology Development - Direct to Phase II (R44) Apply for RFA HG 15 039 Funding Number: RFA HG 15 039 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Applied Research Toward Zero Suicide Healthcare Systems (R01) Apply for RFA MH 16 800 Funding Number: RFA MH 16 800 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA PS 13 00104CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.